Healthcare provider profile · identity verified

Nelson Gonzalez, MD

Family Practice · MIAMI, FL · NPI 1578759197

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	449	133
Metformin Hcl	Metformin Hcl	228	61
Amlodipine Besylate	Amlodipine Besylate	210	63
Lisinopril	Lisinopril	201	51
Eliquis	Apixaban	200	31
Losartan Potassium	Losartan Potassium	199	66
Gabapentin	Gabapentin	178	64
Albuterol Sulfate Hfa	Albuterol Sulfate	177	55
Alprazolam	Alprazolam	176	31
Omeprazole	Omeprazole	173	46
Sildenafil Citrate	Sildenafil Citrate	161	23
Metoprolol Succinate	Metoprolol Succinate	158	49
Levothyroxine Sodium	Levothyroxine Sodium	151	33
Diclofenac Sodium	Diclofenac Sodium	133	66
Fluticasone Propionate	Fluticasone Propionate	133	52
Memantine Hcl	Memantine Hcl	132	38
Glipizide	Glipizide	125	30
Escitalopram Oxalate	Escitalopram Oxalate	97	25
Tamsulosin Hcl	Tamsulosin Hcl	94	27
Furosemide	Furosemide	93	32
Sertraline Hcl	Sertraline Hcl	91	22
Azithromycin	Azithromycin	90	70
Pantoprazole Sodium	Pantoprazole Sodium	83	20
Montelukast Sodium	Montelukast Sodium	80	24
Mirtazapine	Mirtazapine	79	27
Trazodone Hcl	Trazodone Hcl	78	26
Prednisone	Prednisone	77	38
Baclofen	Baclofen	76	42
Clonazepam	Clonazepam	76	12
Tramadol Hcl	Tramadol Hcl	72	21
Hydrochlorothiazide	Hydrochlorothiazide	71	25
Metoprolol Tartrate	Metoprolol Tartrate	69	22
Rosuvastatin Calcium	Rosuvastatin Calcium	62	21
Meclizine Hcl	Meclizine Hcl	61	25
Ibuprofen	Ibuprofen	54	28
Farxiga	Dapagliflozin Propanediol	53	11
Allopurinol	Allopurinol	51	18
Alendronate Sodium	Alendronate Sodium	49	suppressed
Carvedilol	Carvedilol	49	17
Latanoprost	Latanoprost	49	suppressed
Lorazepam	Lorazepam	48	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	47	33
Clopidogrel	Clopidogrel Bisulfate	47	18
Bumetanide	Bumetanide	46	12
Donepezil Hcl	Donepezil Hcl	46	14
Entresto	Sacubitril/Valsartan	46	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	45	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	42	suppressed
Famotidine	Famotidine	41	15
Zolpidem Tartrate	Zolpidem Tartrate	41	suppressed
Ammonium Lactate	Ammonium Lactate	39	19
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	12
Quetiapine Fumarate	Quetiapine Fumarate	39	14
Simvastatin	Simvastatin	39	14
Januvia	Sitagliptin Phosphate	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	37	17
Nifedipine Er	Nifedipine	37	11
Novolog Flexpen	Insulin Aspart	37	suppressed
Fenofibrate	Fenofibrate	36	16
Pioglitazone Hcl	Pioglitazone Hcl	35	suppressed
Clonidine Hcl	Clonidine Hcl	34	14
Tradjenta	Linagliptin	34	suppressed
Citalopram Hbr	Citalopram Hydrobromide	33	suppressed
Chlorthalidone	Chlorthalidone	32	suppressed
Tadalafil	Tadalafil	32	suppressed
Benzonatate	Benzonatate	31	23
Chlordiazepoxide Hcl	Chlordiazepoxide Hcl	31	12
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	11
Xarelto	Rivaroxaban	29	suppressed
Trifluoperazine Hcl	Trifluoperazine Hcl	28	suppressed
Glimepiride	Glimepiride	27	suppressed
Atenolol	Atenolol	26	suppressed
Enalapril Maleate	Enalapril Maleate	26	suppressed
Ketoconazole	Ketoconazole	26	16
Pregabalin	Pregabalin	26	suppressed
Ciclopirox	Ciclopirox Olamine	25	11
Vitamin D2	Ergocalciferol (Vitamin D2)	25	suppressed
Ozempic	Semaglutide	24	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	23	13
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	23	suppressed
Temazepam	Temazepam	23	suppressed
Clobetasol Propionate	Clobetasol Propionate	21	suppressed
Diclofenac Potassium	Diclofenac Potassium	21	11
Jardiance	Empagliflozin	21	suppressed
Irbesartan	Irbesartan	20	suppressed
Spironolactone	Spironolactone	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Folic Acid	Folic Acid	19	suppressed
Novolin 70-30 Flexpen	Insulin Nph Hum/Reg Insulin Hm	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Methotrexate	Methotrexate Sodium	18	suppressed
Timolol Maleate	Timolol Maleate	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	15
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	18	suppressed
Isosorbide Dinitrate	Isosorbide Dinitrate	17	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	17	suppressed
Levetiracetam	Levetiracetam	17	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	17	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	17	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	16	suppressed
Ciclopirox	Ciclopirox	16	11
Humulin 70-30	Insulin Nph Hum/Reg Insulin Hm	16	suppressed
Meloxicam	Meloxicam	16	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Lactulose	Lactulose	15	suppressed
Levofloxacin	Levofloxacin	15	14
Buspirone Hcl	Buspirone Hcl	14	suppressed
Duloxetine Hcl	Duloxetine Hcl	14	suppressed
Finasteride	Finasteride	14	suppressed
Hydralazine Hcl	Hydralazine Hcl	14	suppressed
Cephalexin	Cephalexin	13	11
Insulin Aspart Flexpen	Insulin Aspart	13	suppressed
Jentadueto	Linagliptin/Metformin Hcl	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Lumigan	Bimatoprost	13	suppressed
Aripiprazole	Aripiprazole	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	12
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Sure Comfort	Syringe-Needle,insulin,0.5 Ml	12	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Methylprednisolone	Methylprednisolone	11	11
Metronidazole	Metronidazole	11	11

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error